EVALUATION OF PRESCRIBED CARDIOVASCULAR DRUGS MARKETED BY VARIOUS PHARMACEUTICAL COMPANIES OF BANGLADESH

Abstract

Cardiovascular drugs encompass a large number of prescription medications that are used to control heart disease. It is a complicated group of drugs with many being used for multiple heart conditions. The main objective of this survey was to analyze the prescribed cardiovascular drugs with their brand name marketed by different local and international companies of Bangladesh. This was a descriptive cross-sectional survey involving patients, physicians and pharmacy in-charge based on a structured questionnaire format with answer sets and followed up by prescription monitoring. This study carried out at the outdoor of National Heart Foundation (Mirpur, Dhaka) and the Dhaka medical college hospital Pharmacy (Dhaka, Bangladesh) from January’12 to August’12. From total 700 prescriptions, 99% prescriptions were prescribed by the specialist but only 1% by general physicians. Out of the total patients with a male, female ratio of 57.14: 42.86, all patients were over 30 years and approximately 64.285 % the patients were demographically from urban area whereas 35.714% patients came from rural area. Individual patients got different classes of drugs including Beta-blockers, Organic nitrates, anticoagulant, anti-platelet and thrombolytic agents, Calcium channel blockers, Diuretics, ACE inhibitors, Lipid lowering agents and Miscellaneous agents were respectively 25.00, 19.57, 22.00,8.42,10.42,10.40 and 2.85 percent. This study may be guidelines for optimizing rational use of cardiovascular drugs and also a new statistical approach for effective cardiovascular disease management in Bangladesh.

Keywords: Pharmaceutical Company, Chi-square test, Confidence interval at 95% confidence level, cardiovascular drugs (brand name)